Peptide Therapy at Rogue Revitalize Med Spa in Medford, OR

Elevate Wellness with Personalized Peptide Therapy

Peptide therapy involves the use of small chains of amino acids that act as signaling molecules to support various health and wellness goals. These peptides work by targeting specific receptors in the body to promote benefits such as weight management, muscle growth, tissue repair, hormone balance, and skin rejuvenation. Administered subcutaneously, peptide therapy is personalized based on individual patient needs, with dosing and frequency carefully guided by a licensed physician. Call us to discuss your goals and for personalized recommendations.

Important Update Regarding Peptide Therapy : At Rogue Revitalize Medical Spa & Aesthetics, patient safety , responsible prescribing , and compliance with current federal and state regulations are extremely important to us. Because the regulatory landscape surrounding compounded peptide therapy continues to evolve, we want to keep our patients informed about recent FDA developments and how they affect the peptide therapies we are able to provide.

Currently Rogue Revitalize will not prescribe, dispense, or facilitate access to affected compounded peptides that do not currently meet federal compounding requirements. At this time this includes popular peptides including but not limited to :BPC157, TB500, Wolverine Blend (BPC 157/TB500), MOTS-C, CJC1295, Ipamorelin, Melanotan II, Semax, Epitalon, DSIP, Retatrutide, Kisspeptin.

If and when a peptide becomes legally available for patient-specific compounding and our licensed pharmacy partners are able to provide it in compliance with applicable regulations , we will evaluate whether it is appropriate to return that therapy to our treatment options.

Good news- peptide therapy has NOT been eliminated entirely. There continues to be lawful treatment pathways for certain medications and substances. Depending on the patients medical needs, prescription requirements, formulation, pharmacy availability , and current regulations, Rogue Revitalize may continue to provide or prescribe therapies such as Semorelin, GHK-CU in eligible non-injectable formulations, GLP 1& 2 injectables, NAD+ therapy.

What does this mean for Rogue Revitalize patients? Our providers may still continue to provide general education about peptides, including their mechanisms of action, the research being conducted, potential future applications, available evidence, known and unknown risks , and their current regulatory status. However, education does not mean that a peptide is available for treatment. Rogue Revitalize will not prescribe , dispense, sell , or direct patients to obtain a peptide that does not currently have an appropriate lawful pathway for human use. We also do not recommend purchasing products labeled "research use only" or "not for human consumption" for personal use.

Peptide medicine is a rapidly developing area of research, and regulations can change as new evidence becomes available. At Rogue Revitalize, we would rather temporarily pause a therapy than provide a treatment when its regulatory status is unclear. We will continue to following FDA guidance, working with liscenced compounding pharmacies, and updating our treatment options as regulations evolve.

Patients interested in peptide therapy are still welcome to schedule a consultation. We can discuss your goals, review which therapies are currently available, provide education regarding therapies that are still under review, and discuss appropriate alternatives. We will continue updating this page as the FDA completes its review of BPC-157, KPV, TB-500, MOTS-C, Semax, Epitalon, and other peptide therapies.

Disclaimer: This information is provided for general educational purposes and is not intended to represent that any compounded medication is FDA-approved. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety , effectiveness, or quality before marketing. Treatment availability is subject to applicable federal and state law, pharmacy requirements, medical necessity, and individual provider evaluation.

Availability of any compounded medication is subject to current FDA requirements, Oregon law, pharmacy availability, and individualized medical evaluation.